Navigation Links
Popular herbal supplements may adversely affect chemotherapy treatment

CHICAGO- Acai berry, cumin, herbal tea, turmeric and long-term use of garlic all herbal supplements commonly believed to be beneficial to your health may negatively impact chemotherapy treatment according to a new report presented at the American Society of Clinical Oncology (ASCO) meeting in Chicago this summer. Researchers from Northwestern Memorial hospital say there is growing evidence that these popular supplements may intensify or weaken the effect of chemotherapy drugs and in some cases, may cause a toxic, even lethal reaction.

"With the growth of the Internet, patients have better access to information about alternative products and often turn to dietary and herbal supplements to treat their illness because they think they're natural and safe," said June M. McKoy, MD, geriatrician at Northwestern Memorial Hospital and lead investigator on the ASCO presentation. "What people don't realize is that supplements are more than just vitamins and can counteract medical therapies if not taken appropriately".

McKoy, who is also director of geriatric oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, says more research is needed to understand which supplements interact with chemotherapy drugs and the extent of those interactions and encourages patients to openly communicate with their physicians about the use of supplements.

"Patients need to tell their doctors what medications they are taking including vitamins and supplements to avoid any possible interaction," said McKoy who is also an assistant professor of medicine and preventive medicine at Northwestern University Feinberg School of Medicine.

Herbal supplements, defined as plant or plant parts used for therapeutic purposes, can interact with chemotherapy drugs through different mechanisms. Some herbs can interfere with the metabolism of the drugs, making them less effective while other herbs such as long-term use of garlic may increase the risk of bleeding during surgery. While culinary herbs used in small quantities for flavoring are generally safe, consuming large amounts for prolonged periods of time may have a negative effect on the body when going through chemotherapy.

Recent research shows that 50 percent of patients undergoing chemotherapy did not tell their doctor they were taking alternative therapies. "Some believe it's not important, while others are uncomfortable admitting they are pursuing alternative therapies," said McKoy. "The truth is, integrative approaches can be beneficial for cancer patients, but it's important to take these approaches at the right time and under the supervision of your doctor."

McKoy urges patients to stop taking herbal supplements while receiving chemotherapy until more is known about possible interactions, but encourages those who are interested in complementary approaches to have a conversation with their doctor about other approaches that may be beneficial.

"Integrative therapies such as massage, acupuncture and meditation can address important patient needs by alleviating stress, addressing pain and helping patients cope," said Melinda Ring, MD, medical director for the Northwestern Memorial Physicians Group's Center for Integrative Medicine and Wellness.

No matter the course of treatment, McKoy stresses the importance of physicians and patients being more cognizant of this potential interaction and encourages communication about all herbal supplement intakes. "Patients should bring in labels and bottles to their appointments. This can help the doctor calibrate drug dosage with other supplements in mind in order to prevent toxicities," stated McKoy.

McKoy plans to launch a pilot study this fall to examine how frequently conversations about supplements come up between cancer patients and their doctors.

"By identifying communication barriers, we can take steps to improve doctor patient communication in order to prevent potentially dangerous drug interactions," said McKoy.


Contact: Angela Salerno
Northwestern Memorial Hospital

Related biology news :

1. Sandia, SES win Popular Mechanics Breakthrough Innovator Award
2. New standard for popular stevia-based sweetener to assure products quality
3. Quality and purity of popular stevia sweetener strengthened by new reference standards
4. Study: Popular supplement quercetin does not enhance athletic performance
5. Genomes of 2 popular research strains of E. coli sequenced
6. New edition of popular lab manual presents latest techniques for probing cellular dynamics
7. After 5 years, free systems biology markup language has proven popular
8. Planting depth affects popular landscape tree
9. Popular autism diet does not demonstrate behavioral improvement
10. Mercury levels are increasing in popular species of game fish in Lake Erie
11. OHSU Toxicology Research Center issues public alert on popular hair salon treatment
Post Your Comments:
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... -- Daon, a global leader in mobile biometric authentication ... version of its IdentityX Platform , IdentityX v4.0. ... have already installed IdentityX v4.0 and are seeing ... UAF certified server component as an option and ... These customers include some of the largest and most ...
Breaking Biology News(10 mins):
(Date:12/1/2015)... ALEXANDRIA, Va. , Dec. 1, 2015 ... provides senior debt to life sciences and healthcare services ... senior secured term loan with MDRejuvena, Inc. ("the Company"). ... commercialization and continued development of the Company,s Rejuvaphyl™ and ... --> Rejuvaphyl is the MDRejuvena brand of high ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... announces Park NX10 SICM Module, an add-on scanning ion conductance microscopy module to ... of SICM to an AFM. , Park SICM benefits virtually all materials characterization ...
(Date:12/1/2015)... , Dec. 1, 2015 Cepheid (Nasdaq: ... its participation at the Piper Jaffray Healthcare Conference in ... morning, the Company is reaffirming its outlook for the ... 2016, in addition to discussing longer term business model ... Chief Executive Officer.  "We continue to be the fastest ...
(Date:12/1/2015)... , December 1, 2015 ... addition of the  "2016 U.K. Virology and ... Forecasts for 100 Tests, Supplier Shares by ...  report to their offering.  --> ... the  "2016 U.K. Virology and Bacteriology Testing ...
Breaking Biology Technology: